Genetic linkage studies of type 1 diabetes have produced a number of conflicting results, suggesting a high degree of locus heterogeneity in this disease. Approaches which model such heterogeneity will increase the power to fine map susceptibility loci. Here, using data from a genome scan of 356 affected sib pairs with type 1 diabetes, we performed heterogeneity analysis based on similarity of age at diagnosis of the sib pairs. We observed linkage to the region on chromosome 4p16.3 in sib pairs both diagnosed over the age of 10 years, whilst there was no evidence for linkage in sib pairs diagnosed before age 10 years. In contrast the sib pairs diagnosed before the age of 10 years demonstrated linkage to IDDM10, on chromosome 10p. Age of diagnosis-based heterogeneity analyses in complex diseases may be particularly helpful in mapping some susceptibility loci.
Introduction
Cloning genes for complex diseases is proving to be a difficult task and this is probably due to the absence of major genes, low penetrance of susceptibility alleles on the phenotypes studied, and a high degree of genetic locus heterogeneity. Attempts to reduce the degree of locus heterogeneity using the criterion of age of diagnosis (AOD) has been helpful in the mapping and identification of a number of human disease genes. ). Age-dependent linkage of diabetes to Idd4 has been shown in the NOD mouse model. 3 We hypothesized that using families with affected individuals of similar AOD may be more homogeneous genetically than unselected families, and may show linkage to particular chromosomal regions, and have tested this using data from a large genome scan for type 1 diabetes.
Methods
Pedigree and genotyping data for 351 genome-wide markers for 356 affected sib-pair families from the UK were used (obtained from http://diesel.cimr.cam.ac.uk/todd/). These families were recruited by the British Diabetes Association 4 and include 93 families from the original 'UK96' genome scan, 5 as well as 263 additional families. 6 AOD data were provided by Charles Mein. The AOD distribution in the siblings from these families are presented in Figure 1 , and is bimodally distributed. This reflects the AOD ascertainment scheme used for this study whereby the majority of families recruited had one sibling with AOD < 17 years of age and the other < 29 years. 5, 6 The mean age of diagnosis is 10.3 years (median 10.0 years). Since the mean and median AOD in this data were both close to age 10 years, the families were divided into those where both sibs were affected earlier or at 10 years (n = 130 sib pairs, henceforth termed E) and those where both pairs had onset later than 10 years (n = 95 sib pairs, termed L). This left 131 families in neither group which were not analysed further. Multipoint linkage analysis was performed separately in the E and L groups using the MAP-MAKER SIBS v 2.0 program 7 under the assumption of no dominance variance, reporting the maximum multipoint lod score (MMLS). Alleles had been scored uniquely in each family using a 4-allele system, with the alleles observed in each family numbered 1-4. Since estimates of allele frequencies are required for linkage analysis, we used 1/n for the frequency of each allele at a marker with n alleles. The marker order and sex-averaged inter-marker recombination fractions provided by Dr Todd's web site were used.
Results
Only regions which demonstrate MMLS > 2.0 are reported here. At the HLA region of chromosome 6p, evidence for linkage derived from both early and later onset sib pairs as follows: MMLS = 13.1 for the E group and MMLS = 8.10 from the L group. No difference in the MMLS at HLA between the two groups was seen when the number of families in each group was taken into account. In addition, there was evidence for linkage to chromosome 10 in the region where IDDM10 has been mapped. 5, 6, 8 The peak linkage at this region occurs around markers D10S193-D10S183-D10S208-D10S565 and arises predominantly from the E group (MMLS = 3.2 for E compared with MMLS = 1.2 for L; Figure 2a ). The only other region which produces MMLS > 2 was on the tip of chromosome 4p, where there was evidence for linkage in the L sib pairs close to D4S412 (MMLS = 2.13; Figure 2b ). At the peak of linkage to the L group there was no evidence for linkage to the E group (MMLS = 0.25), but interestingly, there was evidence of linkage in the early onset families more proximally between D4S2366 and D4S431 (MMLS = 1.90), where the L families show much weaker linkage (MMLS = 0.52). No MMLS > 2.0 was observed in either E or L families at the human region that is homologous to mouse Idd4. Because alleles were not scored consistently across families, we assessed whether the results on chromosomes 4 and 10 were dependent on specification of allele frequencies, and used the sib_ibd option of ASPEX v 2.1 9 to determine sharing identical by descent (Table 1) . At D4S412 there are nominally significant differences in allele sharing between E and L groups-at the other markers the differences are not significant, but they do support the findings of the multipoint analyses (Table 1) .
Discussion
This exploratory analysis has not been corrected for multiple statistical comparisons. In the primary analysis of this data 18 loci were reported which met the authors' criteria for linkage, 6 whilst here we report only three chromosomal regions that meet our significance criteria. For the results obtained for chromosome 4 several additional reasons make these regions worthy of further investigation and these are outlined in the following. The linkage results for the E and L groups on chromosome 4p16 are supported by the observation that two diseases that have been mapped to this region exhibit an increased rate of diabetes. Specifically, evidence for linkage of L IDDM sib pairs to the tip of chromosome 4p is of interest since D4S412 is only 2 cM away from the gene responsible for Huntington's disease (HD) in the sex-averaged genetic map. 10 Two studies have reported an increased incidence of abnormal glucose tolerance tests in HD patients. 11, 12 Furthermore, the prevalence of diabetes in a sample of 288 individuals with HD was higher than that in an age-matched representative sample of the US white population, 13 with the mean AOD of diabetes in HD around 35-40 years. 13 Animal studies further support the role of HD in etiology of diabetes. R6/2 mice which have a transgene containing about 140 CAG repeats in part of the human HD gene develop an insulin-responsive diabetes by age 7 weeks, 14 and the pancreata, among other tissues, demonstrate intranuclear inclusions. 15 Another gene closely linked to D4S412 is LRPAP1 (low density lipoprotein receptor-related protein-associated protein 1). LRPAP1 is expressed in human pancreas, and has been shown to contain a binding site for immune deposit-inducing antibodies which are a feature of an experimental autoimmune rat model of human membraneous glomerulonephritis, called passive Heymann nephritis. 16, 17 The above findings suggest that DNA sequence variation in or near either HD or LRPAP1 is a susceptibility factor for later onset type 1 diabetes. The second locus on 4p16.1, between D4S2366 and D4S431 (E MMLS = 1.90), is of interest through it's putative association with the gene for Wolfram syndrome (No. 222300 1 ). Wolfram syndrome is an autosomal recessive disorder, featuring juvenile onset diabetes with a mean onset of 6 years. The gene for Wolfram syndrome (WFS1) maps to the same bacterial artificial chromosome as D4S431. The risk of diabetes in siblings of Wolfram syndrome patients is about 10%. 18, 19 WFS1 has recently been shown to be expressed in pancreatic islet cells 20, 21 making it a strong positional candidate for susceptibility to E-onset IDDM. Since the frequency of mutant WFS1 alleles may be about 0.3-1% further studies are necessary to clarify whether WFS heterozygotes are at increased risk for diabetes.
Evidence for linkage to a locus on chromosome 10p13-q11, termed IDDM10, has previously been provided. 5, 6, 8 However, another group has found only very weak linkage to IDDM10 (MMLS = 0.4 at D10S193 22 ) although some families which they studied overlap with those analysed here. The discrepancy between the results of the two studies could be due to different proportions of E and L families in each sample. Although AOD appears helpful in reducing locus heterogeneity in complex diseases, different age cut-offs likely apply at individual loci. Much larger sample sizes than analysed here will be necessary to clarify whether our results are type 1 errors, and to define AOD distributions at particular IDDM loci. AOD-based heterogeneity tests may assist in the fine mapping and ultimate cloning of susceptibility loci for complex diseases. 
